Vektor Medical Launches vMap, an AI-Powered Data Analytics Tool for Cardiac Arrhythmia Treatment with 91% Accuracy.
Nov 15, 2024
San DiegoBiotechnologyHealthcareHealth CareArtificial IntelligenceMedicalMachine LearningHealth Diagnostics
Product Description
Vektor Medical announced the presentation of new data on its AI-powered vMap algorithm, which showcases a 91.1% accuracy rate in distinguishing epicardial and endocardial ventricular tachycardia. The tool, presented on November 17 at the AHA Scientific Sessions 2024, offers a precise method for localizing arrhythmia sources and is FDA-cleared.
Company Information
Company
Vektor Medical
Location
San Diego, California, United States
About
Vektor Medical is a pioneer in non-invasive, AI-based arrhythmia analysis technology, aiming to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Their flagship product, vMap, is an AI-based, non-invasive arrhythmia analysis tool designed to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency.
Fundz sees it the moment Vektor Medical ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
San DiegoBiotechnologyHealthcareHealth CareArtificial IntelligenceMedicalMachine LearningHealth Diagnostics